Tolerability and dose-related effects of nebivolol in elderly patients with heart failure: Data from the Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS) trial
- 19 June 2007
- journal article
- research article
- Published by Elsevier BV in American Heart Journal
- Vol. 154 (1), 109-115
- https://doi.org/10.1016/j.ahj.2007.03.025
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Tolerability of beta‐blockers in elderly patients with chronic heart failure: The COLA II studyEuropean Journal of Heart Failure, 2006
- The Use of β-Blockers in a Tertiary Care Heart Failure ClinicArchives of Internal Medicine, 2004
- Gender, age, and heart failure with preserved left ventricular systolic functionJournal of the American College of Cardiology, 2003
- beta Blockers in older persons with heart failure: tolerability and impact on quality of lifeHeart, 2002
- The Pathogenesis of Acute Pulmonary Edema Associated with HypertensionNew England Journal of Medicine, 2001
- Survival of patients with a new diagnosis of heart failure: a population based studyHeart, 2000
- Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failureJournal of the American College of Cardiology, 1999
- Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam StudyPublished by Oxford University Press (OUP) ,1999
- Congestive heart failure in old age: prevalence, mechanisms and 4‐year prognosis in the Helsinki Ageing StudyJournal of Internal Medicine, 1997
- Course and Prognosis in Patients ≥70 Years of Age With Congestive Heart Failure and Normal Versus Abnormal Left Ventricular Ejection FractionThe American Journal of Cardiology, 1997